Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.25 and traded as low as $4.00. Evotec shares last traded at $4.04, with a volume of 48,150 shares.
Evotec Stock Performance
The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 9.85 and a beta of 0.98. The stock’s fifty day moving average is $4.62 and its two-hundred day moving average is $4.25. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Recommended Stories
- Five stocks we like better than Evotec
- What is the Shanghai Stock Exchange Composite Index?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- CD Calculator: Certificate of Deposit Calculator
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
